High-grade B-cell lymphoma (HGBL) is a new, provisional entity in the most recent World Health Organization classification,1 and includes cases displaying features intermediate between diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL): the diagnosis is challenging, and the molecular bases of this morphological spectrum are not fully understood.
TABANELLI Valentina;
MELLE Federica;
MOTTA Giovanna;
MAZZARA Saveria;
FABBRI Marco;
CORSINI Chiara;
GERBINO Elvira;
CALLERI Angelica;
SAPIENZA Maria Rosaria;
ABBENE Ignazio;
STUFANO Viviana;
BARBERIS Massimo;
PILERI Stefano A.;
2020-07-27
FONDAZIONE FERRATA STORTI ONLUS
JRC120046
1824-9337 (online),
https://publications.jrc.ec.europa.eu/repository/handle/JRC120046,
10.3324/haematol.2020.249664 (online),
| Name | Country | City | Type |
|---|
This document is only visible at the Commission level.
You are not authorized to publish or distribute it outside the European Commission.
This is a public document. You can share this publication.
Datasets
| ID | Title | Public URL |
|---|
Dataset collections
| ID | Acronym | Title | Public URL |
|---|
Scripts / source codes
| Description | Public URL |
|---|
Additional supporting files
| File name | Description | File type |
|---|